Robert H. Fairclough
Affiliations: | Biochemistry and Molecular Biology | University of California, Davis, Davis, CA |
Area:
Biochemistry, ImmunologyGoogle:
"Robert Fairclough"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Trinh VB, Foster AJ, Fairclough RH. (2014) Design, synthesis, and characterization of a 39 amino acid peptide mimic of the main immunogenic region of the Torpedo acetylcholine receptor. Molecular Immunology. 59: 79-90 |
| Morell SW, Trinh VB, Gudipati E, et al. (2014) Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor. Molecular Immunology. 58: 116-31 |
| Morell SW, Trinh VB, Gudipati E, et al. (2014) Corrigendum to "Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor" [Mol. Immunol. 58 (2014) 116-131] Molecular Immunology. 59: 117 |
| Fairclough RH, Trinh VB, Page NA. (2012) Peptide mimics of the torpedo and human AChR main immunogenic regions F1000research. 3 |
| Agius MA, Richman DP, Fairclough RH, et al. (2003) Three forms of immune myasthenia. Annals of the New York Academy of Sciences. 998: 453-6 |
| Fairclough RH, Agius MA, Gudipati E, et al. (2003) Agonist-induced transitions of the acetylcholine receptor. Annals of the New York Academy of Sciences. 998: 101-13 |
| Fairclough RH, Twaddle GM, Gudipati E, et al. (1998) Differential surface accessibility of α(187-199) in the torpedo acetylcholine receptor α subunits Journal of Molecular Biology. 282: 317-330 |
| Fairclough RH, Twaddle GM, Gudipati E, et al. (1998) Mapping the mAb 383C epitope to alpha 2(187-199) of the Torpedo acetylcholine receptor on the three-dimensional model. Journal of Molecular Biology. 282: 301-15 |
| Agius MA, Zhu S, Kirvan CA, et al. (1998) Rapsyn antibodies in myasthenia gravis Annals of the New York Academy of Sciences. 841: 516-521 |
| Richman DP, Agius MA, Kirvan CA, et al. (1998) Antibody effector mechanisms in myasthenia gravis. The complement hypothesis. Annals of the New York Academy of Sciences. 841: 450-65 |